My NCBI | Sign In
Search: Hevener A[au]
RSS Settings
  • Search: Hevener A[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 29

    1.

    Impaired Oxidative Metabolism and Inflammation are Associated with Insulin Resistance in ER{alpha} Deficient Mice.

    Ribas V, Nguyen MT, Henstridge DC, Nguyen AK, Beaven SW, Watt MJ, Hevener AL.

    Am J Physiol Endocrinol Metab. 2009 Nov 17. [Epub ahead of print]PMID: 19920214 [PubMed - as supplied by publisher]Related articles

    2.

    AMPK lower case Greek beta1 deletion reduces appetite preventing obesity and hepatic insulin resistance.

    Dzamko N, Vandenderen BJ, Hevener AL, Jorgensen SB, Honeyman J, Galic S, Chen ZP, Watt MJ, Campbell DJ, Steinberg GR, Kemp BE.

    J Biol Chem. 2009 Nov 5. [Epub ahead of print]PMID: 19892703 [PubMed - as supplied by publisher]Related articlesFree article

    3.

    Insulin resistance and altered systemic glucose metabolism in mice lacking Nur77.

    Chao LC, Wroblewski K, Zhang Z, Pei L, Vergnes L, Ilkayeva OR, Ding SY, Reue K, Watt MJ, Newgard CB, Pilch PF, Hevener AL, Tontonoz P.

    Diabetes. 2009 Dec;58(12):2788-96. Epub 2009 Sep 9.PMID: 19741162 [PubMed - in process]Related articles

    4.

    Hypermetabolism, hyperphagia, and reduced adiposity in tankyrase-deficient mice.

    Yeh TY, Beiswenger KK, Li P, Bolin KE, Lee RM, Tsao TS, Murphy AN, Hevener AL, Chi NW.

    Diabetes. 2009 Nov;58(11):2476-85. Epub 2009 Aug 3.PMID: 19651815 [PubMed - in process]Related articles

    5.

    Pigment epithelium-derived factor contributes to insulin resistance in obesity.

    Crowe S, Wu LE, Economou C, Turpin SM, Matzaris M, Hoehn KL, Hevener AL, James DE, Duh EJ, Watt MJ.

    Cell Metab. 2009 Jul;10(1):40-7.PMID: 19583952 [PubMed - indexed for MEDLINE]Related articles

    6.

    Examination of 'lipotoxicity' in skeletal muscle of high-fat fed and ob/ob mice.

    Turpin SM, Ryall JG, Southgate R, Darby I, Hevener AL, Febbraio MA, Kemp BE, Lynch GS, Watt MJ.

    J Physiol. 2009 Apr 1;587(Pt 7):1593-605. Epub 2009 Feb 9.PMID: 19204053 [PubMed - indexed for MEDLINE]Related articles

    7.

    HSP72 protects against obesity-induced insulin resistance.

    Chung J, Nguyen AK, Henstridge DC, Holmes AG, Chan MH, Mesa JL, Lancaster GI, Southgate RJ, Bruce CR, Duffy SJ, Horvath I, Mestril R, Watt MJ, Hooper PL, Kingwell BA, Vigh L, Hevener A, Febbraio MA.

    Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1739-44. Epub 2008 Jan 25.PMID: 18223156 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Fluxing the mitochondria to insulin resistance.

    Watt MJ, Hevener AL.

    Cell Metab. 2008 Jan;7(1):5-6.PMID: 18177719 [PubMed - indexed for MEDLINE]Related articles

    9.

    Macrophage peroxisome proliferator activated receptor gamma as a therapeutic target to combat Type 2 diabetes.

    Pascual G, Ricote M, Hevener AL.

    Expert Opin Ther Targets. 2007 Nov;11(11):1503-20. Review.PMID: 18028013 [PubMed - indexed for MEDLINE]Related articles

    10.

    Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.

    Monetti M, Levin MC, Watt MJ, Sajan MP, Marmor S, Hubbard BK, Stevens RD, Bain JR, Newgard CB, Farese RV Sr, Hevener AL, Farese RV Jr.

    Cell Metab. 2007 Jul;6(1):69-78.PMID: 17618857 [PubMed - indexed for MEDLINE]Related articles

    11.

    Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones.

    Hevener AL, Olefsky JM, Reichart D, Nguyen MT, Bandyopadyhay G, Leung HY, Watt MJ, Benner C, Febbraio MA, Nguyen AK, Folian B, Subramaniam S, Gonzalez FJ, Glass CK, Ricote M.

    J Clin Invest. 2007 Jun;117(6):1658-69. Epub 2007 May 24.PMID: 17525798 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Thiazolidinediones enhance skeletal muscle triacylglycerol synthesis while protecting against fatty acid-induced inflammation and insulin resistance.

    Todd MK, Watt MJ, Le J, Hevener AL, Turcotte LP.

    Am J Physiol Endocrinol Metab. 2007 Feb;292(2):E485-93. Epub 2006 Sep 26.PMID: 17003244 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    PPARdelta regulates glucose metabolism and insulin sensitivity.

    Lee CH, Olson P, Hevener A, Mehl I, Chong LW, Olefsky JM, Gonzalez FJ, Ham J, Kang H, Peters JM, Evans RM.

    Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3444-9. Epub 2006 Feb 21.PMID: 16492734 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Ciliary neurotrophic factor prevents acute lipid-induced insulin resistance by attenuating ceramide accumulation and phosphorylation of c-Jun N-terminal kinase in peripheral tissues.

    Watt MJ, Hevener A, Lancaster GI, Febbraio MA.

    Endocrinology. 2006 May;147(5):2077-85. Epub 2006 Jan 5.PMID: 16396984 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Deletion of Gab1 in the liver leads to enhanced glucose tolerance and improved hepatic insulin action.

    Bard-Chapeau EA, Hevener AL, Long S, Zhang EE, Olefsky JM, Feng GS.

    Nat Med. 2005 May;11(5):567-71. Epub 2005 Apr 10.PMID: 15821749 [PubMed - indexed for MEDLINE]Related articles

    16.

    IKK-beta links inflammation to obesity-induced insulin resistance.

    Arkan MC, Hevener AL, Greten FR, Maeda S, Li ZW, Long JM, Wynshaw-Boris A, Poli G, Olefsky J, Karin M.

    Nat Med. 2005 Feb;11(2):191-8. Epub 2005 Jan 30.PMID: 15685170 [PubMed - indexed for MEDLINE]Related articles

    17.

    Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3).

    Wiedmer T, Zhao J, Li L, Zhou Q, Hevener A, Olefsky JM, Curtiss LK, Sims PJ.

    Proc Natl Acad Sci U S A. 2004 Sep 7;101(36):13296-301. Epub 2004 Aug 24.PMID: 15328404 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Effect of endurance training and fasting on renal gluconeogenic enzymes in the rat.

    Sumida KD, Garrett JH, McJilton WT, Hevener AL, Donovan CM.

    Int J Sport Nutr Exerc Metab. 2004 Jun;14(3):323-32.PMID: 15256692 [PubMed - indexed for MEDLINE]Related articles

    19.

    Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.

    He W, Barak Y, Hevener A, Olson P, Liao D, Le J, Nelson M, Ong E, Olefsky JM, Evans RM.

    Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15712-7. Epub 2003 Dec 5.PMID: 14660788 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Muscle-specific Pparg deletion causes insulin resistance.

    Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM, Olefsky J.

    Nat Med. 2003 Dec;9(12):1491-7. Epub 2003 Nov 16.PMID: 14625542 [PubMed - indexed for MEDLINE]Related articles

    21.

    Chronic endothelin-1 treatment leads to insulin resistance in vivo.

    Wilkes JJ, Hevener A, Olefsky J.

    Diabetes. 2003 Aug;52(8):1904-9.PMID: 12882904 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

    Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM.

    Diabetes. 2002 Oct;51(10):2968-74.PMID: 12351435 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Female rats do not exhibit free fatty acid-induced insulin resistance.

    Hevener A, Reichart D, Janez A, Olefsky J.

    Diabetes. 2002 Jun;51(6):1907-12.PMID: 12031980 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Synthesis of an organoinsulin molecule that can be activated by antibody catalysis.

    Worrall DS, McDunn JE, List B, Reichart D, Hevener A, Gustafson T, Barbas CF 3rd, Lerner RA, Olefsky JM.

    Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13514-8. Epub 2001 Nov 13.PMID: 11707596 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats.

    Hevener AL, Reichart D, Janez A, Olefsky J.

    Diabetes. 2001 Oct;50(10):2316-22.PMID: 11574414 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    Hypoglycemic detection does not occur in the hepatic artery or liver: findings consistent with a portal vein glucosensor locus.

    Hevener AL, Bergman RN, Donovan CM.

    Diabetes. 2001 Feb;50(2):399-403.PMID: 11272153 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Exercise and thiazolidinedione therapy normalize insulin action in the obese Zucker fatty rat.

    Hevener AL, Reichart D, Olefsky J.

    Diabetes. 2000 Dec;49(12):2154-9.PMID: 11118020 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Portal vein afferents are critical for the sympathoadrenal response to hypoglycemia.

    Hevener AL, Bergman RN, Donovan CM.

    Diabetes. 2000 Jan;49(1):8-12.PMID: 10615943 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Novel glucosensor for hypoglycemic detection localized to the portal vein.

    Hevener AL, Bergman RN, Donovan CM.

    Diabetes. 1997 Sep;46(9):1521-5.PMID: 9287058 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    6 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity